ISRG — INTUITIVE SURGICAL INC
Health Care · Medical Devices
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
Why are billionaires buying ISRG?
Built from public SEC filings and public economic data. Not a recommendation.
Why? — Evidence & Confidence ▾
Of 4 tracked investors who changed their ISRG position last quarter, 3 bought and 1 sold (75% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 55/100 in a Squeeze regime). 1 congressional purchase, 0 sales disclosed in the last 6 months.
- +3 tracked investors added or increased positions last quarter (Philippe Laffont, Ray Dalio, Cathie Wood)
- +8 tracked investors reported holding ISRG at their latest filing
- +Macro Health is 52/100 in a Squeeze regime — historically acceptable for Health Caresource
- −1 tracked investor reduced or exited last quarter (0 reduced, 1 sold out)
- −13F data is disclosed up to 45 days after quarter end — positions may have changed since
- · 13F disclosure lag (up to 45 days)
- · Tracked investors are a sample, not the whole market
- · Sector regime fit is a historical average, not a guarantee
Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 8/4/2026.
About INTUITIVE SURGICAL INC (ISRG)
INTUITIVE SURGICAL INC (ISRG) appears in the most recent 13F filings of 8 tracked institutional investors. INTUITIVE SURGICAL INC is classified in the Health Care sector (Medical Devices industry). The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $1.2B. Across recent filings, tracked investors recorded 7 new positions, 3 increased, 1 reduced, and 2 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in ISRG
How many top investors track ISRG
Several tracked investors have exposure.
ISRG Ownership Composition
How INTUITIVE SURGICAL INC is held across tracked investor types, based on reported 13F positions.
- Other84.0%
- Hedge Funds14.8%
- Growth Funds1.2%
Tracked investors reporting ISRG
- Ken GriffinMar 31, 2026Citadel AdvisorsShares8.7MValue$1.2B% Portfolio0.20%
- Izzy EnglanderMar 31, 2026Millennium ManagementShares1.6MValue$506.6M% Portfolio0.21%
- Philippe LaffontMar 31, 2026Coatue ManagementShares855.2KValue$394.3M% Portfolio1.36%
- Steve CohenDec 31, 2025Point72 Asset ManagementShares1.2MValue$385.3M% Portfolio0.43%
- Paul Tudor JonesDec 31, 2025Tudor Investment CorpShares147KValue$50.3M% Portfolio0.09%
- Cathie WoodMar 31, 2026ARK Investment ManagementShares69KValue$31.8M% Portfolio0.25%
- Ray DalioMar 31, 2026Bridgewater AssociatesShares17.3KValue$8M% Portfolio0.04%
- David EinhornDec 31, 2023DME Capital Management, LPShares58.5KValue$1.4M% Portfolio0.07%
Recent activity
- Sold$0(-100.00%)Feb 17, 2026
- Sold$0(-100.00%)May 15, 2026
- $50.3MFeb 17, 2026
- $457.2MMay 15, 2026
- $394.3MMay 15, 2026
- $1.5MNov 14, 2023
- $1.4MFeb 14, 2024
- Increased$8M(54.83%)May 15, 2026
- Increased$31.8M(40.52%)May 12, 2026
- Reduced$6.3K(-73.63%)Feb 13, 2026
- Increased$27.8K(64.69%)Feb 11, 2026
- New$5.7KNov 13, 2025
- New$13.3KNov 12, 2025
Frequently asked questions
- How many institutional investors hold ISRG?
- 8 tracked institutional investors disclosed a position in ISRG (INTUITIVE SURGICAL INC) in their most recent 13F filing.
- Who is the largest institutional holder of ISRG?
- Ken Griffin, Citadel Advisors, holds the largest disclosed position in ISRG, valued at $1.2B.
- Did institutional ownership of ISRG increase or decrease?
- Across recent 13F filings, tracked investors recorded 7 new positions, 3 increased, 1 reduced, and 2 fully exited ISRG.
- What sector is ISRG in?
- INTUITIVE SURGICAL INC is classified in the Health Care GICS sector, Medical Devices industry.
- Where does this ISRG ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.